Stejbach Mark
SEC CIK 1487937 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INDV | Indivior Pharmaceuticals, Inc. | Dir | 27.1K | $27.4K | — | 3 | 2026-01-05 | 2026-05-13 |
Most active insiders at INDV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Heidbreder Christian | CSO | — | $1.47M |
| 2 | Preblick Ryan | CFO | — | $1.36M |
| 3 | Anderson Woodrow D | CAO | $108.0K | — |
| 4 | Wheadon David E. | Dir | $62.7K | — |
| 5 | Kingsley Stuart A | Dir | $30.0K | — |
| 6 | Ryan Barbara | Dir | $28.7K | — |
| 7 | Humphreys Keith | Dir | $27.4K | — |
| 8 | Stejbach Mark | Dir | $27.4K | — |
| 9 | NINIVAGGI DANIEL A | Dir | $27.4K | — |
| 10 | Barry Patrick A | Chief Commercial Off | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-14 16:07 | 2026-05-13 | INDV | Indivior Pharmaceuticals, Inc. | Stejbach Mark | Dir | A - Grant | $0.00 | +6,518 | 27.1K | +32% | $0 | |
| 2026-01-28 | 2026-01-26 | INDV | Indivior Pharmaceuticals, Inc. | Stejbach Mark | Dir | A - Grant | $0.00 | +3,722 | 20.6K | +22% | $0 | |
| 2026-01-07 | 2026-01-05 | INDV | Indivior Pharmaceuticals, Inc. | Stejbach Mark | Dir | P - Purchase | $35.39 | +775 | 16.8K | +5% | +$27.4K |
Purchase Sale Sale after option exercise All abbreviations